Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Verified Market Research | PRODUCT CODE: 1623165

Cover Image

PUBLISHER: Verified Market Research | PRODUCT CODE: 1623165

Europe And Nordic Smart Inhaler Market By Sales Channel, By product type, By Indication, By Geographic Scope And Forecast

PUBLISHED:
PAGES: 202 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Single User License
USD 3950
Multi User License
USD 4850
Enterprise User License
USD 7550

Add to Cart

Europe And Nordic Smart Inhaler Market Size And Forecast

According to Verified Market Research, Europe And Nordic Smart Inhaler Market was valued at USD 10.59 Million in 2018 and is expected to witness a growth of 46.36% from 2019 to 2026 and reachUSD 207.25 Million by 2026.

The latest survey on Europe And Nordic Smart Inhaler Market is conducted covering various organizations of the industry from different geographies to come up with a 100+ page report. The study is a perfect mix of qualitative and quantitative information highlighting key market developments, challenges that industry and competition are facing along with gap analysis and new opportunities available and trend in Europe And Nordic Smart Inhaler Market. The report aims to present the analysis of Europe And Nordic

Smart Inhaler Market

By Sales Channel, By product type, By Indication, By Region - North America, Europe, South America, Asia-Pacific, Middle East, and Africa. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities.

What is Smart Inhaler?

A smart inhaler can be defined as a respiratory inhaler that is equipped with a digital sensor. The sensor tracks data such as dosage timing monitors the use of the inhaler and schedules the next dosage. Smart Inhalers are able to generate alerts for everyday dosage using smart devices like phones or tablets connected to the sensors via Bluetooth. Smart inhalers are designed to treat respiratory disorders such as asthma and COPD. Asthma, which is one of the leading chronic diseases in children, and chronic obstructive pulmonary disease (COPD) are major global concerns for national health-care systems as they significantly affect the quality of life of individuals.

Europe And Nordic Smart Inhaler Market Outlook

An increasing number of individuals suffering from asthma and chronic obstructive diseases is expected to drive the market. The prevalence of asthma and chronic pulmonary disease has increased dramatically in the past few years and this change is observed not only in industrialized countries. These diseases continue to be an important cause of morbidity, health-care costs and even mortality worldwide. Factors that are affecting the increasing prevalence include cigarette smoking, exposure to indoor and outdoor air pollution, occupational hazards, and infections.

The lack of awareness regarding symptoms of respiratory diseases is expected to hinder the market growth rate over the forecast period Respiratory diseases impose an immense worldwide health burden. There are several factors that can trigger the onset of respiratory diseases such as tobacco smoke (second hand as well), indoor and outdoor air pollutants, allergens and occupational agents and possible risk factors include diet and nutrition and more. As COPD symptoms often don't appear until significant lung damage has occurred (and they usually worsen over time, particularly if exposure to the cause continues), the symptoms or their significance is often overlooked by the population. This lack of awareness is restraining the growth of the smart inhalers market.

Europe And Nordic Smart Inhaler Market Segmentation

Europe And Nordic Smart Inhaler Market are segmented on the basis of sales channel product type, indication, and geography. The gist of breaking down the market into various segments is to gather information about various aspects of the market.

Europe And Nordic Smart Inhaler Market By Sales Channel

On the basis of the sales channel, the market is bifurcated into hospital pharmacies, retail pharmacies, and online pharmacies. Hospital pharmacies are business-critical to any hospital as they essentially work to strengthen the three important pillars of the hospital namely, Patient Care, Product Care, and Profit Care. When looked at the perspective of smart inhalers which are already in their nascent stage, most of the companies are offering their products through the hospitals. This is due to the fact that many products haven't got the FDA approvals and are hence not yet being commercialized.

Europe And Nordic Smart Inhaler Market By Product Type

On the basis of product type, Europe And Nordic Smart Inhaler Market have been segmented into dry powder inhaler (DPI), and metered-dose inhaler (MDI). Metered Dose Inhaler is a type of aerosol drug delivery treatment, one of the most commonly used to treat several respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. These inhalers deliver a specific quantity of drugs to the lungs in the form of the aerosolized drug to provide faster pharmacological action. The smart version of these inhalers engages in empowering patient care, leading to improved adherence, by tracking, recording and sharing data on the use of both preventer (controller) and reliever (rescue) medications.

Europe And Nordic Smart Inhaler Market By Indication

On the basis of Indication, Europe And Nordic Smart Inhaler Market have been segmented into asthma, and COPD (Chronic Obstructive Pulmonary Disease). Asthma is one of the common non-communicable diseases that has is estimated to have affected as many as 339 million people worldwide. This segment is anticipated to encounter the largest market share, owing to the rise in prevalence of asthma due to lifestyle changes in terms of food habits, low level of exercise and increased prevalence of pollution and smoking.

Europe And Nordic Smart Inhaler Market, By Country:

  • Europe primarily comprises six countries - Germany, the UK, France, Sweden, Denmark and the Rest of Europe. The UK accounted for the largest share in the market and the rapid growth is owing to factors such as the increasing prevalence of respiratory disorders, such as COPD, TB, Asthma, and Sleep Apnea, technological advancements and increasing applications in the homecare settings.
  • Europe And Nordic Smart Inhaler Market Competitive Landscape:
  • The "Europe And Nordic Smart Inhaler Market" study report offers a valuable insight with an emphasis on the global market including some of the major players such as BIOCORP, H&T Presspart Manufacturing Ltd, Propeller Health, AptarGroup, Inc., Amiko Digital Health Limited, and FindAir. Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.
  • Key Developments in Europe And Nordic Smart Inhaler Market
  • Company Name
  • Key Development
  • Description
  • BIOCORP
  • Agreement
  • BIOCORP and VARI (Subsidiary of LINDAL GROUP) signed strategic partnership
  • To promote and commercialize Inspire in Eastern Europe, South America, the Middle East, and Southeast Asia.
  • H&T Presspart
  • Product Launch
  • H&T Presspart and Cohero Health Inc. launched eMDIe
  • Propeller Health
  • Partnership
  • Propeller Health and Orion Corporation signed a partnership
  • The partnership enabled to connect the Propeller's platform Easyhaler inhalers
  • It expanded Propeller's presence in Europe
  • Top Trending Reports
  • Global Aluminum Rolling Oil Market Size By Process, By Aluminum Type, By Geographic Scope And Forecast
  • Europe And Mena Smart Irrigation Market Size By Component, By Application, By Geographic Scope And Forecast
  • Research Methodology of Verified Market Research:
  • To know more about the Research Methodology and other aspects of the research study, kindly
  • Get in touch with our sales team at Verified Market Research.
  • Reasons to Purchase this Report
  • Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
  • Customization of the Report
  • In case of any
  • Queries or Customization Requirements
Product Code: 15611

TABLE OF CONTENTS

1 INTRODUCTION 8

  • 1.1 MARKET DEFINITION AND TRENDS 8
  • 1.2 INDUSTRY DEVELOPMENTS & INNOVATION 9
  • 1.3 REGULATORY SCENARIO 11
    • 1.3.1 EUROPEAN LAWS AND REGULATIONS 11
  • 1.4 MARKET SEGMENTATION 13
  • 1.5 RESEARCH TIMELINES 14
  • 1.6 ASSUMPTIONS 14
  • 1.7 LIMITATIONS 15

2 RESEARCH METHODOLOGY 16

  • 2.1 DATA MINING 16
  • 2.2 SECONDARY RESEARCH 16
  • 2.3 PRIMARY RESEARCH 16
  • 2.4 SUBJECT MATTER EXPERT ADVICE 16
  • 2.5 QUALITY CHECK 17
  • 2.6 FINAL REVIEW 17
  • 2.7 DATA TRIANGULATION 17
  • 2.8 BOTTOM-UP APPROACH 18
  • 2.9 TOP DOWN APPROACH 18
  • 2.10 RESEARCH FLOW 19
  • 2.11 DATA SOURCES 19

3 EXECUTIVE SUMMARY 20

  • 3.1 MARKET OVERVIEW 20
  • 3.2 EUROPE AND NORDIC SMART INHALER MARKET, BY SALES CHANNEL (USD MILLION) 21
  • 3.3 EUROPE AND NORDIC SMART INHALER MARKET, BY PRODUCT TYPE (USD MILLION) 22
  • 3.4 EUROPE AND NORDIC SMART INHALER MARKET, BY INDICATION (USD MILLION) 23
  • 3.5 FUTURE MARKET OPPORTUNITIES 24

4 MARKET OUTLOOK 25

  • 4.1 EUROPE AND NORDIC SMART INHALER MARKET OUTLOOK 25
  • 4.2 MARKET DRIVERS 26
    • 4.2.1 INCREASING PREVALENCE OF INDIVIDUALS SUFFERING FROM ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASES 26
  • 4.3 MARKET RESTRAINTS 27
    • 4.3.1 THE LACK OF AWARENESS REGARDING SYMPTOMS OF RESPIRATORY DISEASES 27
  • 4.4 MARKET OPPORTUNITIES 28
    • 4.4.1 TECHNOLOGICAL ADVANCEMENTS IN THE DEVELOPMENT OF BETTER SMART INHALER DEVICES AND SYSTEMS 28
  • 4.5 MARKET CHALLENGES 29
    • 4.5.1 HIGH COST 29
  • 4.6 PORTERS FIVE FORCE MODEL 30
  • 4.7 VALUE CHAIN ANALYSIS 31
    • 4.7.1 VALUE CHAIN ANALYSIS FOR THE SMART INHALER MARKET 31

5 MARKET, BY SALES CHANNEL 32

  • 5.1 OVERVIEW 32
  • 5.2 HOSPITAL PHARMACIES 33
  • 5.3 RETAIL PHARMACIES 33
  • 5.4 ONLINE PHARMACIES 33

6 MARKET, BY PRODUCT TYPE 35

  • 6.1 OVERVIEW 35
  • 6.2 DRY POWDER INHALER (DPI)- BASED SMART INHALERS 36
  • 6.3 METERED DOSE INHALER (MDI)- BASED SMART INHALERS 37

7 MARKET, BY INDICATION 38

  • 7.1 OVERVIEW 38
  • 7.2 ASTHMA 39
  • 7.3 COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE) 39

8 MARKET, BY EUROPE REGION 41

  • 8.1 EUROPE 41
    • 8.1.1 GERMANY 43
    • 8.1.2 UK 45
    • 8.1.3 FRANCE 47
    • 8.1.4 SWEDEN 49
    • 8.1.5 DENMARK 51
    • 8.1.6 REST OF EUROPE 53

9 COMPETITIVE LANDSCAPE 55

  • 9.1 OVERVIEW 55
  • 9.2 COMPETITIVE SCENARIO 55
  • 9.3 COMPANY MARKET RANKING ANALYSIS 56

10 COMPANY PROFILES 57

  • 10.1 BIOCORP 57
    • 10.1.1 COMPANY OVERVIEW 57
    • 10.1.2 COMPANY INSIGHTS 57
    • 10.1.3 PRODUCT BENCHMARKING 58
    • 10.1.4 KEY DEVELOPMENTS 58
  • 10.2 H&T PRESSPART MANUFACTURING LTD 59
    • 10.2.1 COMPANY OVERVIEW 59
    • 10.2.2 COMPANY INSIGHTS 59
    • 10.2.3 PRODUCT BENCHMARKING 59
    • 10.2.4 KEY DEVELOPMENTS 60
  • 10.3 PROPELLER HEALTH (RESMED) 61
    • 10.3.1 COMPANY OVERVIEW 61
    • 10.3.2 COMPANY INSIGHTS 61
    • 10.3.3 PRODUCT BENCHMARKING 62
    • 10.3.4 KEY DEVELOPMENTS 62
  • 10.4 APTAR GROUP, INC. 63
    • 10.4.1 COMPANY OVERVIEW 63
    • 10.4.2 COMPANY INSIGHTS 63
    • 10.4.3 SEGMENT BREAKDOWN 64
    • 10.4.4 PRODUCT BENCHMARKING 64
    • 10.4.5 KEY DEVELOPMENTS 64
  • 10.5 AMIKO DIGITAL HEALTH LIMITED 65
    • 10.5.1 COMPANY OVERVIEW 65
    • 10.5.2 COMPANY INSIGHTS 65
    • 10.5.3 PRODUCT BENCHMARKING 65
    • 10.5.4 KEY DEVELOPMENTS 66
  • 10.6 FINDAIR 67
    • 10.6.1 COMPANY OVERVIEW 67
    • 10.6.2 COMPANY INSIGHTS 67
    • 10.6.3 PRODUCT BENCHMARKING 67
    • 10.6.4 KEY DEVELOPMENTS 68
Product Code: 15611

LIST OF TABLES

  • TABLE 1 EUROPE AND NORDIC SMART INHALER MARKET, BY SALES CHANNEL, 2017 - 2026 (USD MILLION) 33
  • TABLE 2 EUROPE AND NORDIC SMART INHALER MARKET, BY PRODUCT TYPE, 2017 - 2026 (USD MILLION) 36
  • TABLE 3 EUROPE AND NORDIC SMART INHALER MARKET, BY INDICATION, 2017 - 2026 (USD MILLION) 39
  • TABLE 4 EUROPE AND NORDIC SMART INHALER MARKET, BY COUNTRY, 2017 - 2026 (USD MILLION) 42
  • TABLE 5 GERMANY SMART INHALERS MARKET, BY SALES CHANNEL, 2017 - 2026 (USD MILLION) 43
  • TABLE 6 GERMANY SMART INHALERS MARKET, BY PRODUCT TYPE, 2017 - 2026 (USD MILLION) 43
  • TABLE 7 GERMANY SMART INHALERS MARKET, BY INDICATION, 2017 - 2026 (USD MILLION) 44
  • TABLE 8 U.K. SMART INHALERS MARKET, BY SALES CHANNEL, 2017 - 2026 (USD MILLION) 45
  • TABLE 9 U.K. SMART INHALERS MARKET, BY PRODUCT TYPE, 2017 - 2026 (USD MILLION) 45
  • TABLE 10 U.K. SMART INHALERS MARKET, BY INDICATION, 2017 - 2026 (USD MILLION) 46
  • TABLE 11 FRANCE SMART INHALERS MARKET, BY SALES CHANNEL, 2017 - 2026 (USD MILLION) 47
  • TABLE 12 FRANCE SMART INHALERS MARKET, BY PRODUCT TYPE, 2017 - 2026 (USD MILLION) 47
  • TABLE 13 FRANCE SMART INHALERS MARKET, BY INDICATION, 2017 - 2026 (USD MILLION) 48
  • TABLE 14 SWEDEN SMART INHALERS MARKET, BY SALES CHANNEL, 2017 - 2026 (USD MILLION) 49
  • TABLE 15 SWEDEN SMART INHALERS MARKET, BY PRODUCT TYPE, 2017 - 2026 (USD MILLION) 49
  • TABLE 16 SWEDEN SMART INHALERS MARKET, BY INDICATION, 2017 - 2026 (USD MILLION) 50
  • TABLE 17 DENMARK SMART INHALERS MARKET, BY SALES CHANNEL, 2017 - 2026 (USD MILLION) 51
  • TABLE 18 DENMARK SMART INHALERS MARKET, BY PRODUCT TYPE, 2017 - 2026 (USD MILLION) 51
  • TABLE 19 DENMARK SMART INHALERS MARKET, BY INDICATION, 2017 - 2026 (USD MILLION) 52
  • TABLE 20 REST OF EUROPE AND NORDIC SMART INHALER MARKET, BY SALES CHANNEL, 2017 - 2026 (USD MILLION) 53
  • TABLE 21 REST OF EUROPE AND NORDIC SMART INHALER MARKET, BY PRODUCT TYPE, 2017 - 2026 (USD MILLION) 53
  • TABLE 22 REST OF EUROPE AND NORDIC SMART INHALER MARKET, BY INDICATION, 2017 - 2026 (USD MILLION) 54
  • TABLE 23 COMPANY MARKET RANKING ANALYSIS 56
  • TABLE 24 KEY DEVELOPMENTS 56
  • TABLE 25 BIOCORP: PRODUCT BENCHMARKING 58
  • TABLE 26 BIOCORP: KEY DEVELOPMENTS 58
  • TABLE 27 H&T PRESSPART MANUFACTURING LTD: PRODUCT BENCHMARKING 59
  • TABLE 28 H&T PRESSPART MANUFACTURING LTD: KEY DEVELOPMENTS 60
  • TABLE 29 PROPELLER HEALTH (RESMED): PRODUCT BENCHMARKING 62
  • TABLE 30 PROPELLER HEALTH (RESMED): KEY DEVELOPMENTS 62
  • TABLE 31 APTAR GROUP, INC.: PRODUCT BENCHMARKING 64
  • TABLE 32 APTAR GROUP, INC.: KEY DEVELOPMENTS 64
  • TABLE 33 AMIKO DIGITAL HEALTH LIMITED: PRODUCT BENCHMARKING 65
  • TABLE 34 AMIKO DIGITAL HEALTH LIMITED: KEY DEVELOPMENTS 66
  • TABLE 35 FINDAIR: PRODUCT BENCHMARKING 67
  • TABLE 36 FINDAIR: KEY DEVELOPMENTS 68

LIST OF FIGURES

  • FIGURE 1 EUROPE AND NORDIC SMART INHALER MARKET SEGMENTATION 13
  • FIGURE 2 RESEARCH TIMELINES 14
  • FIGURE 3 DATA TRIANGULATION 17
  • FIGURE 4 MARKET RESEARCH FLOW 19
  • FIGURE 5 DATA SOURCES 19
  • FIGURE 6 EUROPE AND NORDIC SMART INHALER MARKET OVERVIEW 20
  • FIGURE 7 EUROPE AND NORDIC SMART INHALER MARKET, BY SALES CHANNEL (USD MILLION)21
  • FIGURE 8 EUROPE AND NORDIC SMART INHALER MARKET, BY PRODUCT TYPE (USD MILLION) 22
  • FIGURE 9 EUROPE AND NORDIC SMART INHALER MARKET, BY INDICATION (USD MILLION) 23
  • FIGURE 10 FUTURE MARKET OPPORTUNITIES 24
  • FIGURE 11 EUROPE AND NORDIC SMART INHALER MARKET OUTLOOK 25
  • FIGURE 12 CAUSES OF CHRONIC RESPIRATORY DISEASES 27
  • FIGURE 13 PORTERS FIVE FORCE MODEL 30
  • FIGURE 14 VALUE CHAIN ANALYSIS 31
  • FIGURE 15 EUROPE AND NORDIC SMART INHALER MARKET, BY SALES CHANNEL 32
  • FIGURE 16 EUROPE AND NORDIC SMART INHALER MARKET, BY PRODUCT TYPE 35
  • FIGURE 17 EUROPE AND NORDIC SMART INHALER MARKET, BY INDICATION 38
  • FIGURE 18 EUROPE MARKET SNAPSHOT 41
  • FIGURE 19 KEY STRATEGIC DEVELOPMENTS 55
  • FIGURE 20 BIOCORP: COMPANY INSIGHT 57
  • FIGURE 21 H&T PRESSPART MANUFACTURING LTD: COMPANY INSIGHT 59
  • FIGURE 22 PROPELLER HEALTH (RESMED): COMPANY INSIGHTS 61
  • FIGURE 23 APTAR GROUP, INC.: COMPANY INSIGHT 63
  • FIGURE 24 APTAR GROUP, INC.: SEGMENT BREAKDOWN 64
  • FIGURE 25 AMIKO DIGITAL HEALTH LIMITED: COMPANY INSIGHT 65
  • FIGURE 26 FINDAIR: COMPANY INSIGHT 67
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!